Member Info for Tiptree

With a drop in SP today, maybe it's a good time to review the facts as stated in the NHS Health Research Authority, last amended 29th April.

The Report states: "If SNG001 proves to be beneficial it would be a major breakthrough for the treatment of COVID-19."

Were there to be any official concerns about the potential for SNG001 to deliver, or to be affordable as a palliative resource, this would surely not be continuing.

You've probably seen this already, but in case you want to refresh your memory about the upside of your investment:

https://www.hra.nhs.uk/covid-19-research/approved-covid-19-research/281317/

What has Lord Bethell tweeted - last one I can see was yesterday, on Prof. Newton?

Hard to call this either way but your comment about Booker is perceptive. Four points - Booker can't be doing so well at the moment due to customer closures. Tesco seem to be coming out on top in terms of adjusting to present conditions when compared to competitors. No need for bogof's etc., at this point, although those would have been funded in the main by suppliers. If one likens Tesco to Amazon's situation, Amazon's sales were up significantly of course, but their profit margins are down as a result of extra costs.

In my view, Tesco is an exceptionally well-run business these days.

Definitely don't filter him - joined three days ago and posts 110 times on ODX. Cracks me up!

Within 1p of highest SP in the last year and Sharepad showing 79% of yesterday's full day volume already. Different feel to it.

Embarrassing; it just hit 60 and I thought about getting out. But didn't. You said it!

Not sure that there will be a '2pm RNS' or even any today, but as something that could significantly affect the SP, one could well argue that an RNS that comments on SG016 would be fair to shareholders. Why not actually?

Ground-breaking idea and one that will help speed up data collection and may show the way forward to reducing the need for hospitalisation!

Have to agree with everything you say Theroller. I felt the same after posting a cautionary (and genuine) message before open this morning, when euphoria took over on this board. I was a bit surprised to have 'officemanager' post an abusive response but once I'd checked his profile for other posts, realised it's what he does, almost without exception in his posts.
Personally I don't think you should close off from this board, it needs a balance and as much intelligent discourse as it can get, but can't blame you. NCYT is now a 'grown up' share. Bon chance!

https://www.boursorama.com/cours/1rPALNOV/

As mentioned a couple of times today, this is now more of an investor's share rather than an outright gamble. Hurrah!

Up slightly less than 10%. Be careful folks.

French theoretical opening: +4%. Four.

Absolutely. If SP ends the day up by more than 20% I’ll be amazed.

It's somewhat bizarre actually. When you look at all the COVID-19 related shares, this is the one which has something that works and is selling in increasingly-greater volumes. Wish we could actually work out the value of the business by any conventional methods; but we can't!

Very true. Some don't worry about chasing so-called 'multi-baggers'. Take 15%, 20% or 25% as a target and get out if you hit that. You are in control and if a share keeps going up, buy back in - you won't have lost a lot but you might have saved your profit!
Lots of people have been trading NCYT for example, working between the RNSs.

Results are not coming on Thursday. Check recent RNS for more information.

Quickdraw where are you getting those figures from? Worldometers shows approx 150,000 cases reported, by definition almost all of those being hospitalisations. Approx 20,000 deaths in hospital equates to 1 in 7.5, around 15% (not 96%). That figure will rise as a proportion of hospitalisations., but may in fact reduce as we get to grips with how to deal with this without palliative medication and resources are less stretched.

With the graph tailing off now, it's even if there were as many deaths in the next eight weeks as there have been so far (and I doubt that very much) the total would be under 40,000. You estimate 120,000 - why?

Sweden's death rate is not 69%, rather it is about 1 in 9 so far, let's say 11%.

Just curious to understand your calculations, not disputing the gravity of the situation.

tyla I should have chosen Mercedes F1 rather than Red bull perhaps, to illustrate my point. The only 'car brand' team I know of that is involved in the engineering side of F1 is Ferrari and even then, it's not really the same thing. I haven't checked lately either, but think Ferrari is the only F1 team not based in UK. Even Renault is based in Enstone, UK, with only the engine coming from France.

Just because the car will be branded Aston Martin, there is no likelihood of there being an engineering connection, beyond the F1 to Road Car technical development sharing. That is normal and has been for some years now. It kind of spoils things for long-time followers like me, but at least we can be proud perhaps that the UK is quite definitely the centre of the F1 universe. And it's great that the Mercedes F1 involvement in CPAP design improvement and manufacture was intended for UK use, although they have made it open-source design.

Stay safe!

https://www.mercedesamgf1.com/en/news/2020/04/ucl-uclh-f1-project-pitlane-start-delivery-breathing-aids-nhs-hospitals/

What - like Red Bull?